Stage 4 lung cancer patient lives cancer-free after successful lung transplant

Written By :  Isra Zaman
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-03-27 23:45 GMT   |   Update On 2022-03-27 23:43 GMT

In a medical breakthrough, a successful lung transplant for a terminal stage 4 lung cancer patient was performed by surgeons at Norwestern medicine. The tumor, though in stage 4, had not metastasized and was luckily encasing both of the patient's lungs, which is a rare event.After half a year, the patient, Albert Khoury, had no signs of any cancer in the body which brings rays of hope for...

Login or Register to read the full article

In a medical breakthrough, a successful lung transplant for a terminal stage 4 lung cancer patient was performed by surgeons at Norwestern medicine. The tumor, though in stage 4, had not metastasized and was luckily encasing both of the patient's lungs, which is a rare event.

After half a year, the patient, Albert Khoury, had no signs of any cancer in the body which brings rays of hope for other lung cancer patients, the press release mentions.

"Lung transplantation for lung cancer is extremely uncommon with few cases reported," said Ankit Bharat, MD, chief of thoracic surgery at Northwestern Medicine and executive director of the canning Thoracic Institute, who is also a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. "For patients with stage 4 cancer, lung transplantation is considered a complete 'no-no,' but because Albert's cancer was confined only to his chest, we were confident we could clear all the cancer during surgery and save his life."

The 54-year-old patient who was a non-smoker used to work as a cement finisher where he developed the symptoms of cold which were later detected as stage 1 lung cancer which progressed to terminal stage 4 cancer because of delay in treatment due to Covid-19 surge.

"One of the biggest fears of performing a transplant on anyone who has cancer is the risk of recurrence after the transplant," said Dr. Bharat. "All transplant patients require medications to control their immune system, which has an immune-suppressive effect. The concern is that if you suppress someone's immune system and they have lingering cancer cells in the body, those will flare up very quickly."

Because the outcome was so successful, Drs. Bharat and Chae are developing a new set of protocols for treating lung cancer patients at Northwestern Medicine, and they're currently in the process of starting a clinical registry to track the progress of such patients over time.

Tags:    
Article Source : Norwestern medicine newsroom

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News